NCT06062134View on ClinicalTrials.gov

Pericapsular Nerve Group Block: An Imaging Study for Determination of the Spread of the Injectate Using 3-D CT Scan

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

December 21, 2023

Study Completion Date

December 21, 2023

Conditions
Post Operative PainMechanisms of Analgesia
Interventions
PROCEDURE

Pericapsular nerve group block

Ultrasound-guided injection of local anesthetic mixed with contrast agent underneath the iliopsoas muscle, lateral to the iliopsoas tendon.

DRUG

18 mL ropivacaine 0.5% + 2 mL radiopaque contrast

20 mL of injectate: 18 mL ropivacaine 0.5% + 2 mL radiopaque contrast (Iomeron 300: 61.24% w/v of iomeprol equivalent to 30% iodine or 300 mg iodine/mL)

Trial Locations (1)

1070

Clinique Ste Anne-St Remi, Brussels

All Listed Sponsors
lead

Philippe Gauthier

OTHER

NCT06062134 - Pericapsular Nerve Group Block: An Imaging Study for Determination of the Spread of the Injectate Using 3-D CT Scan | Biotech Hunter | Biotech Hunter